Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148320
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148320
Heart Failure POC and LOC Devices Market, By Device Type, By Test Type, By Biomarker, By Technology, By Application, By End User, By Geography
PUBLISHED:
PAGES: 256 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Heart Failure POC and LOC Devices Market is estimated to be valued at USD 185.7 Mn in 2026 and is expected to reach USD 498.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 15.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 185.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 15.10% | 2033 Value Projection: | USD 498.4 Mn |
Heart failure is a chronic, progressive disease of the cardiovascular system affecting more than 64 million people worldwide, where the heart fails to pump sufficient blood to meet the body's oxygen and metabolic needs. The increasing disease burden is driving the need for rapid and accurate diagnostic solutions for biomarkers such as BNP, NT-proBNP, troponin.
Point-of-Care (POC) and Lab-on-Chip (LOC) devices are enabling rapid and decentralized cardiac testing in emergency departments, clinics, and home-care settings. Progress in microfluidics, biosensors, nanotechnology, and digital health is making these technologies more portable, accurate, and efficient, thus facilitating their expanding contribution to modern heart-failure diagnosis and monitoring.
Market Dynamics
The global heart failure POC and LOC devices market is driven by increase in the prevalence of heart failure as well as increase in the aging population along with increase in the prevalence of hypertension, diabetes, obesity and coronary artery disease. The increase in the preference for decentralized patient-centric care and advances in microfluidics, biosensors, wireless connectivity and artificial intelligence is further increasing the demand for rapid and accurate cardiac diagnostics in emergency, outpatient and remote-care settings.
However, a number of constraints are present in the market, such as high development and manufacturing costs, strict regulatory requirements, accuracy concerns, limited healthcare infrastructure, and reimbursement challenges. Nevertheless, growing demand for home-based cardiac monitoring, IoT-connected diagnostics, cloud-based data management, and predictive analytics, coupled with improving healthcare access in emerging economies will offer new opportunities for growth in the global heart failure POC and LOC devices market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global heart failure POC and LOC devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Danaher Corporation, QuidelOrtho Corporation, bioMerieux S.A., Becton, Dickinson and Company, Trinity Biotech plc, Jant Pharmacal Corporation, and Werfen, S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global heart failure POC and LOC devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global heart failure POC and LOC devices market
Market Segmentation
- Device Type Insights (Revenue, USD Mn, 2021 - 2033)
- Point-of-Care (POC) Devices
- Lab-on-Chip (LOC) Devices
- Test Type Insights (Revenue, USD Mn, 2021 - 2033)
- Proteomic Testing
- Metabolomic Testing
- Genomic Testing
- Biomarker Insights (Revenue, USD Mn, 2021 - 2033)
- BNP/NT-proBNP
- Troponin
- Multi-Biomarker Panels
- Others
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Microfluidics
- Array-Based Systems
- Immunoassay-Based Systems
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Acute Heart Failure Diagnosis
- Chronic Heart Failure Monitoring
- Risk Stratification and Readmission Prevention
- Therapy Optimization
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Specialty Cardiology Centers
- Primary Care and Urgent Care Centers
- Diagnostic Laboratories
- Homecare and Remote Patient Monitoring
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- Danaher Corporation
- QuidelOrtho Corporation
- bioMerieux S.A.
- Becton, Dickinson and Company
- Trinity Biotech plc
- Jant Pharmacal Corporation
- Werfen, S.A.
Product Code: CMI10035
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Heart Failure POC and LOC Devices Market, By Device Type
- Global Heart Failure POC and LOC Devices Market, By Test Type
- Global Heart Failure POC and LOC Devices Market, By Biomarker
- Global Heart Failure POC and LOC Devices Market, By Technology
- Global Heart Failure POC and LOC Devices Market, By Application
- Global Heart Failure POC and LOC Devices Market, By End User
- Global Heart Failure POC and LOC Devices Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Device Type Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Heart Failure POC and LOC Devices Market, By Device Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Point-of-Care (POC) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lab-on-Chip (LOC) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Heart Failure POC and LOC Devices Market, By Test Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Proteomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Metabolomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Genomic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Heart Failure POC and LOC Devices Market, By Biomarker, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- BNP/NT-proBNP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Troponin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Multi-Biomarker Panels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Heart Failure POC and LOC Devices Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Array-Based Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunoassay-Based Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Heart Failure POC and LOC Devices Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Acute Heart Failure Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chronic Heart Failure Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Risk Stratification and Readmission Prevention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Therapy Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Heart Failure POC and LOC Devices Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Specialty Cardiology Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Primary Care and Urgent Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Homecare and Remote Patient Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Heart Failure POC and LOC Devices Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Device Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Biomarker, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffmann-La Roche Ltd.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- QuidelOrtho Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux S.A.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trinity Biotech plc
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jant Pharmacal Corporation
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
- Werfen, S.A.
- Company Highlights
- Device Type Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.